Health Care / Medicine
-
Health Care / Medicine
‘A Proactive And Necessary Step:’ NFPRHA Applauds Proposed Rule On Birth Control Coverage
Under the proposed new rule, employers are no longer able to be exempt from covering contraception due to moral convictions, but religious exemptions still remain. It's an important move from the government during the reproductive health crisis, one advocate said. -
Health Care / Medicine
GoodRx Illegally Sold Users’ Data To Google & Facebook, FTC Says
GoodRx failed to notify users that it sold their personal health information to Google, Facebook, and other tech companies, the FTC claimed. The agency filed an order that prohibits GoodRx from sharing its users' data with third parties for advertising purposes and requires the company to pay a $1.5 million penalty. GoodRx agreed to pay the settlement but did not admit to wrongdoing. - Sponsored
Early Adopters Of Legal AI Gaining Competitive Edge In Marketplace
How to best leverage generative AI as an early adopter with ethical use. -
Courts
Court Rules Johnson & Johnson Can't Throw Out Civil Liability Because Of ’Good Intentions’
The next phase of the litigation will be them repeatedly saying, ’Cancer? How could we have given you cancer? Do you see how cute our mascot is?!’
-
Health Care / Medicine
What Health Plans Need To Know About QHPs Now That The ACA Is Here To Stay
Now that numerous calls for repeal and legal challenges brought against the ACA over the years have failed, health plans can finally invest confidently in this line of business. -
Health Care / Medicine
How Will FDA Guidance Impact Decentralized Clinical Trials In 2023?
The agency’s goal is to spur a macro shift in clinical trials. The FDA is trying to tell these companies what it wants to be different in trials across the board with regards to digital health endpoints, the use of real-world data (RWD) as regulatory-grade data, and diversity in clinical trial inclusion. -
Health Care / Medicine
After JPM, What Are The Legal Dealmaking Trends To Watch?
After another insightful conference this year, these are some of the key legal deal trends to expect from the health care and life sciences industries in 2023. -
Health Care / Medicine
Debate Rages Between NPs And Docs On Whether Nurses Should Operate Independently
A contentious debate regarding whether or not nurse practitioners should have more freedom and be less tethered to doctors continues as lawmakers in Pennsylvania spark discussion. -
Health Care / Medicine
UPMC’s Monopoly Keeps Wages Low And Prevents Workers From Unionizing, Lawmakers Say
Two Pennsylvania lawmakers are warning their constituents about UPMC, claiming the health system has built a monopoly that negatively affects both employee wellbeing and patient safety. They said UPMC has ‘considerable power over workers, which it wields to keep wages low, conditions unsatisfactory and prevent union organizing.’ - Sponsored
Navigating Financial Success by Avoiding Common Pitfalls and Maximizing Firm Performance
In this CLE-eligible webinar, we’ll explore the most common accounting pitfalls and how to avoid them for your firm. -
Health Care / Medicine
The No Surprises Act And ‘Good Faith Estimate’: What Is It And When Is It Required
For patients that are uninsured or not using their insurance and choosing to pay out of pocket, providers are required to give a patient an estimate of all reasonably expected costs ahead of time, referred to as the Good Faith Estimate (GFE). -
Health Care / Medicine
Dry(ish) January: How One Company Is Helping Consumers Drink In Moderation
Sunnyside is promoting ‘Dry(ish)’ January that promotes drinking in moderation versus complete sobriety. The company offers a direct-to-consumer app that helps users make a plan for their drinking and provides peer coaching. -
Biglaw
Biglaw Firm's Decision To Cover Abortion-Related Travel Expenses Didn't Please All Partners -- But The Firm Never Wavered
The firm's leader knew he couldn't make everyone happy, but he did what he thought was 'right.' -
Health Care / Medicine
4 Health Systems Invest In A Cybersecurity Startup As Threats Loom
MemorialCare, Ballad Health, Cedars-Sinai, and UNC REX Healthcare recently participated in Censinet’s $9 million funding round. The company’s flagship product is a cloud-based network that allows healthcare organizations to share and manage risk data to strengthen cybersecurity planning. -
Health Care / Medicine
Ending Involuntary Commitments Would Shift Burden Of Montana’s Dementia Care To Strapped Communities
A budget estimate attached to proposed legislation in Montana raises questions about whether the state's cash-strapped communities will have the capacity to care for patients with Alzheimer’s disease, other types of dementia, or traumatic brain injuries by July 2025, when involuntary commitments would cease under the plan.
Sponsored
Sponsored
Is The Future Of Law Distributed? Lessons From The Tech Adoption Curve
The rise of remote work has dramatically reshaped the relationship between Lawyers and Law Firms, see how Scale LLP has taken the steps to get…
Sponsored
Early Adopters Of Legal AI Gaining Competitive Edge In Marketplace
How to best leverage generative AI as an early adopter with ethical use.
Sponsored
Navigating Financial Success by Avoiding Common Pitfalls and Maximizing Firm Performance
In this CLE-eligible webinar, we’ll explore the most common accounting pitfalls and how to avoid them for your firm.
Sponsored
Sponsored
The Business Case For AI At Your Law Firm
ChatGPT ushers in the age of generative AI – even for law firms.
Sponsored
Legal AI: 3 Steps Law Firms Should Take Now
If 2023 introduced legal professionals to generative AI, then 2024 will be when law firms start adapting to utilize it. Things are moving fast, so…
-
Health Care / Medicine
Claiming Insulin Price Conspiracy, CA Sues Lilly, Novo Nordisk, Sanofi & PBMs
California's Office of the Attorney General contends that drugmakers and pharmacy benefit managers work together to ‘aggressively raise the list price of insulin in lockstep with each other to artificial levels.’ Insulin manufacturers deny the allegations, pointing to availability of lower-cost versions of their products. -
-
Health Care / Medicine, Intellectual Property
Sanofi CEO: We Don’t Have A Leaky Bathtub
In a media briefing during the J.P. Morgan Healthcare Conference in San Francisco, Paul Hudson said unlike Sanofi, large pharma companies with top-selling drugs have a portfolio akin to a leaky bathtub because in a few years, they will have to replace much of that revenue as drug patents expire. -
Health Care / Medicine
From JPM Week: Trends That Life Science Experts Are Watching In 2023
Boston Consulting Group hosted a panel during the annual J.P. Morgan Healthcare Conference in which Merck's chief strategy officer, a healthcare leader from Goldman Sachs, an investment executive, and a senior medical devices executive from Medtronic weighed in on trends the life sciences industry can expect to see in 2023. -
Health Care / Medicine
Drug Approvals In 2022: A Recap Of Notable FDA Regulatory Decisions
Fewer new drugs won FDA approvals in 2022 compared to previous years, but some of the products that passed regulatory muster are indicative of trends expected to continue into 2023. For example, more gene and cell therapies are on track to face regulatory decisions in the coming year. -
Health Care / Medicine
How Much Of A Risk Is A Potential Class-Action Lawsuit Against CommonSpirit?
CommonSpirit Health is facing a proposed class-action lawsuit over a ransomware attack it suffered last fall that exposed 623,774 patients' personal data. However, hospitals' data breach lawsuits usually never make it court, a legal expert said. -
Health Care / Medicine, Technology
Which Health Tech Companies Might Go Public Or Get Acquired In 2023?
As macroeconomic forces continue to negatively impact the healthcare sector, health tech experts predict that 2023 will be another slow year for the IPO market. However, they think consolidation deals will continue to be a constant, according to a new report.